← Back to Clinical Trials
Recruiting NCT06173167

NCT06173167 Clinical Evaluation of Full Contour Zirconia Chairside CAD/CAM Crowns

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06173167
Status Recruiting
Phase
Sponsor Ivoclar Vivadent AG
Condition Dental Disorders Hard Tissues of Teeth
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-01-08
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Crowns self-adhesively lutedCrowns conventionally cemented

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2024-01-08 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This investigation will be a randomized, prospective, longitudinal clinical trial to study the clinical performance of a new monolithic, zirconia material with shade, translucency and material graduation for chairside CAD/CAM crowns. The restorations will be luted either with a self-adhesive luting material or a conventional cement. The crowns will be evaluated for a period of two years.

Eligibility Criteria

Inclusion Criteria: * at least 18 years of age * at least one carious lesion, defective restoration, or fractured portion of the tooth to be restored on a maxillary or mandibular premolar or molar tooth - Each lesion, fracture, or defective restoration should exhibit sufficient size or loss of tooth structure requiring a full crown restoration. * tooth should have at least one opposing tooth in occlusion and one adjacent tooth with an intact proximal contact * No more than ten teeth that are endodontically treated may be included in the study, equally divided between the two groups of crowns. All remaining teeth in the study will test vital and be asymptomatic at the beginning of treatment. * No more than two restorations will be placed per patient Exclusion Criteria: * Sensitive teeth * Teeth with a history of direct or indirect pulp capping procedures * Patients with significant untreated dental disease to include periodontitis and/or rampant caries * Women who self-report that they are possibly pregnant, pregnant, or lactating, as elective dental treatment is not indicated at these times * Patients with a self-reported history of allergies to the materials to be used in the study including composite resin cements or zirconia restorative materials * Patients unable to return for the recall appointments

Contact & Investigator

Central Contact

Dennis J. Fasbinder, DDS

✉ djfas@umich.edu

📞 (734) 647-4450

Principal Investigator

Dennis J. Fasbinder, DDS

PRINCIPAL INVESTIGATOR

University of Michigan

Frequently Asked Questions

Who can join the NCT06173167 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Disorders Hard Tissues of Teeth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06173167 currently recruiting?

Yes, NCT06173167 is actively recruiting participants. Contact the research team at djfas@umich.edu for enrollment information.

Where is the NCT06173167 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT06173167 clinical trial?

NCT06173167 is sponsored by Ivoclar Vivadent AG. The principal investigator is Dennis J. Fasbinder, DDS at University of Michigan. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology